A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
Clinical trial NCT04346888 · COMPLETED
Trial details
- NCT number
- NCT04346888
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2021-08-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.